BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Unaudited standalone and consolidated financial results for the quarter ended 31.12.2024 and to consider fund raising options .